'The most wonderful time of the year' for advisers
Andrew Aldridge (Partner & Head of Marketing, Deepbridge) recently spoke about tax year end and the importance of speed of deployment when considering an EIS investment.
REQUEST E-APPLICATION FORM | 01244 746000 | Log in
Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.
Investments in unquoted companies carry high risks and investors could lose all funds invested. No established market exists for the trading of shares in private companies, making it difficult to sell shares. The value of tax reliefs depend on personal circumstances and may be subject to change in the future. Investors are encouraged to take independent legal, tax and financial advice before considering an investment.
By clicking below, you confirm that you are an FCA authorised firm or individual and agree to be directed to our website, which is for FCA authorised firms and individuals only. Persons who do not meet this classification should leave this page.
If you are not a professional financial adviser, please contact the Deepbridge Investor Relations Team on 01244 746000 or by email at enquiries@deepbridgecapital.com.
Andrew Aldridge (Partner & Head of Marketing, Deepbridge) recently spoke about tax year end and the importance of speed of deployment when considering an EIS investment.
At Deepbridge Capital we are extremely proud of our team and the individuals who go that extra mile to help those in need. On this occasion, all credit goes to Terri Action, our Internal Account Manager here at Deepbridge.
We are delighted to hear that Dr Kam Pooni, CEO at Deepbridge investee company Glyconics, has been listed for Cofinitive's Top 21 to Watch shortlist.
Elasmogen, which are part of the Deepbridge Life Sciences EIS portfolio, has been announced as a finalist in the Innovative Collaboration award at Scotland's Life Sciences Awards.
Sky Medical, which is part of the Deepbridge Technology Growth EIS portfolio, have been crowned winner of the Innovation Award at Medilink's North of England Healthcare Business Awards 2020.
For your information, we have now updated the following documents for the Deepbridge IHT Service.
Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk.
What are the key risks?
1. You could lose all the money you invest
2. You are unlikely to be protected if something goes wrong
3. You won’t get your money back quickly
4. Don’t put all your eggs in one basket
5. The value of your investment can be reduced
If you are interested in learning more about how to protect yourself, visit the FCA’s website here. [https://www.fca.org.uk/investsmart]